| Literature DB >> 28602616 |
Alexandre Casimiro de Macedo1, José Evandro Cunha1, Juliana Navarro Ueda Yaochite1, Clodis Maria Tavares2, Aparecida Tiemi Nagao-Dias3.
Abstract
Considering that the main route of Mycobacterium leprae transmission is the upper respiratory tract, detection of salivary antibodies can be a useful tool for diagnosing early infection. The study aimed to analyze salivary anti-PGL-1 IgA and IgM antibodies in 169 children aged 4-16 years old, who lived nearby or inside the house of multibacillary or paucibacillary leprosy patients in two endemic cities in Alagoas State - Brazil. Salivary anti-PGL-1 antibodies were quantified by modified ELISA method. The frequency of contact and clinical form of the index case were significantly associated with salivary antibody levels. High frequency of IgM positivity strongly suggests active transmission of M. leprae in these communities. We suggest in the present work that salivary anti-PGL IgA and IgM are important biomarkers to be used for identifying communities with probable active transmission of M. leprae.Entities:
Keywords: Leprosy; Mycobacterium leprae; Phenolic glycolipid-1 antigen; Salivary antibodies
Mesh:
Substances:
Year: 2017 PMID: 28602616 PMCID: PMC9425475 DOI: 10.1016/j.bjid.2017.05.001
Source DB: PubMed Journal: Braz J Infect Dis ISSN: 1413-8670 Impact factor: 3.257
Titers of salivary anti-PGL1 IgA and IgM in 169 young contacts of leprosy patients according to the age range of leprosy contacts, their degree and frequency of relationship with the index case.
| Salivary antibody isotype | ||||||
|---|---|---|---|---|---|---|
| Age range (years) | IgM | IgA | ||||
| 4–6 | 7–11 | 12–16 | 4–6 | 7–11 | 12–16 | |
| 26 | 84 | 59 | 26 | 84 | 59 | |
| Antibody titers (median) | 0.032 | 0.070 | 0.050 | 0.087 | 0.115 | 0.102 |
| Antibody titers (interquartile range) | 0.010–0.109 | 0.026–0.428 | 0.018–0.270 | 0.050–0.155 | 0.062–0.226 | 0.06–0.183 |
| Kruskall–Wallis test, | 0.149 | 0.312 | ||||
N.m. = not mentioned.
p < 0.05 in relation to daily relationship.
Fig. 1Levels of salivary anti-PGL-1 antibodies in 169 young contacts of leprosy patients. (A) Median and range of salivary anti-PGL1 IgM and IgA in contacts of multibacillary (MB contacts, n = 115) and paucibacillary (PB contacts, n = 40) leprosy patients. (B) Median and range of salivary anti-PGL1 IgM and IgA levels in household (HH, n = 57) and peridomiciliar (PD, n = 112) contacts. Salivary anti-PGL-1 antibodies were detected by modified ELISA method.